Clinical Trials Browser

Phase 2 × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Bortezomib × Clear all

NCT06648889 2026-01-15

Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma